Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells
Open Access
- 1 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (42) , 68503-68512
Abstract
Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cellsKeywords
This publication has 41 references indexed in Scilit:
- Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyondLeukemia & Lymphoma, 2013
- Targeting T cells to tumor cells using bispecific antibodiesCurrent Opinion in Chemical Biology, 2013
- Antibody–peptide–MHC fusion conjugates target non-cognate T cells to kill tumour cellsCancer Immunology, Immunotherapy, 2013
- Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemiaClinical Pharmacology: Advances and Applications, 2013
- Assessing the In Vitro and In Vivo Toxicity of Superparamagnetic Iron Oxide NanoparticlesChemical Reviews, 2011
- Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stressInternational Journal of Nanomedicine, 2010
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialInternational Journal of Cancer, 2010
- Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibodyBritish Journal of Cancer, 2009
- Treatment of Malignant Pleural Effusion With the Trifunctional Antibody Catumaxomab (Removab) (Anti-EpCAM×Anti-CD3)Journal of Immunotherapy, 2009
- In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)Cancer Immunology, Immunotherapy, 2008